Clinical Trial Update: Effect of TU-100 in Patients With Functional Constipation [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the effects of TU-100 (Daikenchuto) in patients with functional constipation has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Constipation

Drugs mentioned

• TU-100 (Daikenchuto)

Snippet

Sponsor: Tsumura USA | Conditions: Functional Constipation | Phase 2 | Status: COMPLETED